Ian T Clark sold $245k of GH
director at Guardant Health, Inc.. 8,318 shares at an average of $29.45, traded Nov 12, 2024, filed Nov 14, 2024.
Score components
- +15RoleDirector
- +13Trade size$245k at market
- +10Share of holdings soldSold 50% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +15.1%, 3m +55.5%, 6m +33.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001576280-24-000279, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 12, 2024 | MOption exercise Common Stock | +1,076 | $4.18 | $4,498 | 16,753 | Nov 14, 2024 |
| Nov 12, 2024 | SOpen-market sale Common Stock | -1,076 | $29.52 | $32k | 15,677 | Nov 14, 2024 |
| Nov 12, 2024 | SOpen-market sale Common Stock | -7,242 | $29.44 | $213k | 8,435 | Nov 14, 2024 |
| Nov 12, 2024 | JOther Common Stock | -8,435 | $0.00 | $0 | 0 | Nov 14, 2024 |
| Nov 12, 2024 | JOther Common Stockindirect: By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account | +8,435 | $0.00 | $0 | 8,435 | Nov 14, 2024 |
| Nov 12, 2024 | MOption exercise Stock Option (Right to Buy)derivative | -1,076 | $0.00 | $0 | 0 | Nov 14, 2024 |
Related signals
Other insiders at Guardant Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | Guardant Health, Inc. | Alex M Azar II director | $145k 826 shares | -50% | |
| 55Moderate | Guardant Health, Inc. | Darya Chudova Chief Technology Officer | $1.4M 7,738 shares | -10% | |
| 65Notable | Guardant Health, Inc. | Steve E. Krognes director | $1.2M 6,674 shares | -46% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $20k 116 shares | -1% | |
| 50Moderate | Guardant Health, Inc. | Kumud Kalia Chief Information Officer | $632k 4,000 shares | -9% | |
| 3Weak | Guardant Health, Inc. | Musa Tariq director | $5,069 116 shares | -3% | |
| 31Weak | Guardant Health, Inc. | Kumud Kalia Chief Information Officer | $151k 3,500 shares | -15% | |
| 0Weak | Guardant Health, Inc. | Meghan V. Joyce director | $4,271 100 shares | -1% | |
| 3Weak | Guardant Health, Inc. | Musa Tariq director | $5,606 116 shares | -4% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $4,359 116 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.